19
Participants
Start Date
December 31, 2007
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Bevacizumab
5 mg/kg By Vein Every 2 Weeks x 3 Doses (Weeks 1, 3, 5)
Capecitabine
Starting Dose 650 mg/m\^2 By Mouth Twice Daily Monday-Friday x 6 Weeks
Erlotinib
Starting Dose 50 mg By Mouth Daily Weeks 1-3
Radiation Therapy
30 minute radiation treatments, dose of 50.4 Gy once daily on 5 consecutive days, for up to 5 weeks and 3 days, totaling 28 treatments
Surgery
At least 8 weeks after radiation therapy, surgical removal of rectal tumor
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER